Medicine and Dentistry
Colorectal Liver Metastasis
100%
Randomized Controlled Trial
72%
Hepatic Portal Vein
66%
Thrombectomy
50%
Hepatectomy
49%
Revascularization
41%
Metastatic Carcinoma
38%
Blood Clot Lysis
37%
Systematic Review
33%
Cholangiocarcinoma
33%
Stenosis
33%
Fenestrated Endovascular Aneurysm Repair
33%
Critical Limb Ischemia
33%
Umbilical Vein
33%
Alteplase
33%
Endoleak
33%
Liver Transplantation
33%
Embolization
33%
Biliary Tract Drainage
33%
Portal Vein Thrombosis
33%
Meta-Analysis
33%
Pediatrics
33%
Group Trial
33%
Radiation Therapy
33%
Microwave Thermotherapy
33%
Noninferiority Trial
33%
Surgery
33%
Stereotactic Body Radiation Therapy
31%
Fenestration
30%
Neoplasm
28%
Percutaneous Transluminal Angioplasty
27%
Limb Salvage
27%
Overall Survival
26%
Local Therapy
24%
Disease
21%
Renal Artery
20%
Odds Ratio
16%
Treatment Group
16%
Adverse Event
16%
Hazard Ratio
16%
Adjuvant Therapy
13%
Progression Free Survival
12%
Intention-to-Treat Analysis
11%
Streptokinase
11%
Disease Burden
11%
Interim Analysis
11%
Fibrinolytic Therapy
9%
Hemihepatectomy
8%
Liver Surgery
8%
Tumor Progression
8%
Keyphrases
Meta-analysis
33%
Systematic Meta-analysis
33%
Recombinant Tissue Plasminogen Activator (rt-PA)
33%
Surgical Revascularization
33%
Thrombolysis
33%
Revascularization
33%
Endovascular Revascularization
33%
Acute Limb Ischemia
33%
Multicenter Randomized Controlled Trial
33%
Microwave Ablation
33%
Colorectal Liver Metastases
33%
Stereotactic Ablative Radiotherapy
33%
Stereotactic Body Radiotherapy
25%
Catheter
22%
Portal Shunt
19%
Randomized Controlled Trial
18%
Confidence Interval
16%
Thrombectomy
16%
Odds Ratio
16%
Limb Salvage
16%
Progression-free Survival
12%
Hemorrhagic Complications
11%
Endovascular
11%
Major Vascular Injury
11%
Streptokinase
11%
Limb Salvage Rate
11%
Left Portal Vein
8%
Extended Hemihepatectomy
8%
Hepatoduodenal Ligament
8%
Tumor
8%
Local Tumor Progression
8%
Local Control
8%
Tumor Resectability
6%
Irreversible Electroporation
6%
Perihilar
6%
Urokinase
5%
No Significant Difference
5%
Outcome Reporting
5%
High Dose
5%
AngioJet
5%
Ultrasound
5%
Hybrid Method
5%
Embase
5%
Cochrane Library
5%
Initial Treatment
5%
Thrombolytic Therapy
5%
Low Quality Data
5%
Fibrinolytic Agents
5%
Standardized Practices
5%
High Risk
5%